India IVF, a pioneering fertility provider founded by Dr Richika Sahay and Dr Somendra Shukla, has secured $1.25 million in pre-Series A funding from Tomorrow Capital, a $100 million venture capital fund dedicated to supporting early-stage, transformative consumer healthcare businesses.

This investment represents India IVF's first external funding since its inception, following a decade of profitable operations across its five North Indian centres, which include clinics in Delhi NCR and Srinagar.

This new funding from Tomorrow Capital will drive India IVF's expansion across North India, enabling the company to bridge critical gaps in fertility care access.

With the goal of making advanced fertility solutions accessible to underserved communities, India IVF has established India's first tech-enabled fertility platform, offering comprehensive, 360-degree fertility care through advanced technology and a dedicated team of experts. Tomorrow Capital's investment follows its recent support of VitusCare and IndiShreshtha, further reinforcing its commitment to specialized healthcare ventures.

From its beginnings as a single-room clinic in Gurugram, India IVF has grown into one of North India's leading fertility providers. The IVF market in India, valued at $793.27 million in 2020, is projected to reach $3.72 billion by 2030, with growth driven by rising infertility rates, increased adoption of IVF, and regulatory advancements such as the ART Act, which is establishing higher standards for clinic infrastructure. However, IVF remains under-penetrated in many regions, requiring patients from smaller towns to travel to major cities for treatment.